Treatment of fibromyalgia incorporating EEG-Driven stimulation: a clinical outcomes study.

Thirty patients from a private clinical practice who met the 1990 American College of Rheumatology criteria for fibromyalgia syndrome (FS) were followed prospectively through a brainwave-based intervention known as electroencephalograph (EEG)-driven stimulation or EDS. Patients were initially treated with EDS until they reported noticeable improvements in mental clarity, mood, and sleep. Self-reported pain, then, having changed from vaguely diffuse to more specifically localized, was treated with very modest amounts of physically oriented therapies. Pre- to posttreatment and extended follow-up comparisons of psychological and physical functioning indices, specific FS symptom ratings, and EEG activity revealed statistically significant improvements. EDS appeared to be the prime initiator of therapeutic efficacy. Future research is justified for controlled clinical trials and to better understand disease mechanisms.

Unacknowledged versus acknowledged rape victims: situational factors and posttraumatic stress.

Investigators of sexual assault have found that a substantial number of women who have been raped do not conceptualize their experiences as such. The present investigation examined differences between 40 unacknowledged rape victims and 20 women who acknowledged their experience as rape in a sample of college women, as well as a control group of 23 nonvictims. Groups were compared in terms of situational factors, postassault symptomatology, defense mechanisms, dissociative disorders, and sexual revictimization. In comparison to unacknowledged victims, acknowledged victims reported more forceful assaults and indicated more resistance and clearer refusal. Acknowledged victims exhibited more posttraumatic stress disorder symptoms than unacknowledged victims, who exhibited more symptoms than nonvictims, as measured by clinical interview. Implications of these findings are discussed.

Transdermal fentanyl for cancer pain. Repeated dose pharmacokinetics.

BACKGROUND: The transdermal therapeutic system (fentanyl), or TTS(fentanyl), continuously delivers fentanyl for up to 72 h. The transdermal therapeutic system (fentanyl)-100 delivers approximately 100 micrograms/h. The repeated dose pharmacokinetics of this drug using the recommended dosing interval have not been evaluated previously and were determined in the present study. METHODS: Blood samples were obtained from ten opioid-tolerant cancer patients who received five applications of TTS(fentanyl) at 72-h intervals. A sample of venous blood was taken before each dose; multiple samples were taken during and after the fifth application. A gas chromatographic/mass spectrometry method was used to assay fentanyl (limit of detection 0.2 ng/ml). RESULTS: For the fifth dose, the mean (SD) maximum concentration was 2.6 (1.3) ng/ml and the mean (SD) area under the serum fentanyl concentration-time curve (0-72 h) was 116.9 (59.9). Following removal of the system, the mean (SD) apparent half-life was 21.9 (8.9) h. There were no differences among the serum fentanyl concentrations measured before the second through fifth doses. Fentanyl absorption was 47% complete at 24 h, 88% complete at 48 h, and 94% complete at 72 h. The mean (SD) dose delivered during the 72-h period was 4.3 (1.1) mg. A first-dose trough concentration predicted from fifth-dose kinetics and the actual first-dose trough concentration were very similar. Adverse effects ascribed to the transdermal system were minimal. CONCLUSIONS: These results suggest that steady-state serum concentrations are approached by the second dose of TTS(fentanyl) and that the kinetics are stable with repeated dosing. The apparent half-life following system removal is relatively long, indicating ongoing absorption from a subcutaneous depot.

Perceived risk, stigma, and potential economic impacts of a high-level nuclear waste repository in Nevada.

This study investigates the potential impacts of the proposed nuclear waste repository at Yucca Mountain, Nevada, upon tourism, retirement and job-related migration, and business development in Las Vegas and the state. Adverse impacts may be expected to result from perceptions of risk, stigmatization, and socially amplified reactions to "unfortunate events" associated with the repository (major and minor accidents, discoveries of radiation releases, evidence of mismanagement, attempts to sabotage or disrupt the facility, etc.). The conceptual underpinnings of risk perception, stigmatization, and social amplification are discussed and empirical data are presented to demonstrate how nuclear images associated with Las Vegas and the State of Nevada might trigger adverse economic effects. The possibility that intense negative imagery associated with the repository may cause significant harm to Nevada's economy can no longer be ignored by serious attempts to assess the risks and impacts of this unique facility. The behavioral processes described here appear relevant as well to the social impact assessment of any proposed facility that produces, uses, transports, or disposes of hazardous materials.

Perceived risk, trust, and the politics of nuclear waste.

The Department of Energy's program for disposing of high-level radioactive wastes has been impeded by overwhelming political opposition fueled by public perceptions of risk. Analysis of these perceptions shows them to be deeply rooted in images of fear and dread that have been present since the discovery of radioactivity. The development and use of nuclear weapons linked these images to reality and the mishandling of radioactive wastes from the nation's military weapons facilities has contributed toward creating a profound state of distrust that cannot be erased quickly or easily. Postponing the permanent repository and employing dry-cask storage of wastes on site would provide the time necessary for difficult social and political issues to be resolved.

Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations.

Morphine-6-glucuronide (M-6-G) is an active metabolite that may contribute to the clinical effects produced by systemic administration of morphine. To help clarify the extent to which M-6-G may cross the blood-brain barrier and exert effects, we employed high-performance liquid chromatography with electrochemical detection to measure the concentrations of M-6-G and morphine in the plasma and either ventricular (three patients) or lumbar (eight patients) CSF of cancer patients receiving chronic morphine therapy. The mean ratio of morphine in ventricular CSF:morphine in plasma was 0.71; the same ratio for M-6-G was only 0.077. The average molar ratio of M-6-G: morphine in ventricular CSF was 0.207, and the average molar ratio in plasma was 1.89. Although sampling problems render the lumbar CSF results less reliable, they were very similar. Thus, plasma contained approximately twice as much M-6-G as morphine, whereas CSF contained only one-fifth to one-third as much. These data confirm that M-6-G in plasma is distributed into CSF, but to a far lesser extent than morphine. They help explain animal data demonstrating much higher potency of M-6-G on administration into CSF than systemic administration and indicate that the degree to which M-6-G contributes to morphine effects in humans remains an unresolved question.

Evaluation of antibiotic susceptibility testing by agar dilution and the Micro Media system (Fox Panel).

The susceptibilities of 350 gram-positive cocci and 638 gram-negative bacilli to various antimicrobial agents were compared by using the Micro-Media system (MMS) (Fox Panel) (Micro-Media Systems, Inc., Potomac, Md.) and a standard agar dilution procedure. Major discrepancies occurred with enterococci, among which 48 of 53 isolates (91%) were found to be resistant to penicillin G by agar dilution and reported as susceptible by the MMS. Other large discrepancies occurred with Staphylococcus aureus and Acinetobacter calcoaceticus subsp. anitratus, among which more than 40% of the isolates were judged to be resistant to ampicillin by agar dilution and susceptible by the MMS. In terms of overall agreement in interpretation of MICs by the two systems, an agreement of greater than 84% was seen for both gram-positive and gram-negative organisms when ampicillin and cephalothin (68 and 78% agreement for gram-positive cocci, respectively) were excluded. These disagreements in MIC interpretations may result in part from the small number of organisms tested per well (4,000 CFU) in the MMS, as compared with 10,000 CFU per test in the agar dilution method.

Evaluation of two bioluminescence-measuring instruments, the Turner Design and Lumac systems, for the rapid screening of urine specimens.

Two bioluminescence-measuring instruments, the Turner Design and Lumac systems, were compared with a standard plate culture method for their ability to rapidly screen 400 urine specimens. For cultures with less than 1,000 CFU/ml the Turner Design, with old and new evaluation formulas, gave 6.5 and 50.6% false-positive results, respectively, versus 17.6% at greater than or equal to 500 relative light units with the Lumac. For cultures which had greater than 10(5) CFU/ml the Turner Design gave 39% (old formula) and 14% (new formula) false-negative results compared with 4% at less than 200 relative units with the Lumac. The microorganisms most frequently isolated in the false-negative cultures from either system were gram-positive cocci. Predictive values for a positive test at greater than 10(5) CFU/ml were 77.4% (old formula) and 35.7% (new formula) for the Turner Design versus only 50% for the Lumac at greater than or equal to 500 relative light units. Predictive values for a negative test for both instruments were greater than 88% at greater than 10(5) CFU/ml. The Turner Design and Lumac systems were 4.0 and 3.7 times as expensive, respectively, as the plate culture method. Although both systems greatly reduce the time required to process urine specimens, their high costs as compared with that of plate culture, their failure to detect many specimens having greater than 10(5) CFU of gram-positive cocci per ml, and the numerous false-positives reported by both instruments suggest that additional improvements in the systems are warranted.

Evaluation of the MS-2 and Lumac systems for the rapid screening of urine specimens.

The authors have evaluated the MS-2 (Abbott) and Lumac (3M) systems for the rapid screening of urine specimens for bacteriuria. These systems, which can detect significant levels of microorganisms in urine in five hours (MS-2) or 30 minutes (Lumac), were compared with a standard overnight plate culture method. Three hundred fifty-eight voided urine specimens were examined. The two systems compared equally at greater than 10(5) colony-forming units (CFU)/mL in terms of false-positive results (11%), false-negative results (2%), sensitivity (98%), specificity (approximately equal to 86%), and positive predictive value (98%), although the Lumac was found to have a lower negative predictive value (by 10%) than the MS-2. The only organism not recognized by the MS-2 at greater than 10(5) CFU/mL was a Lactobacillus; whereas the only specimens missed by the Lumac at greater than 10(5) CFU/mL were two pure cultures of Escherichia coli. At counts of greater than 10(4) to 10(5) CFU/mL, both systems missed numerous (15 of 21 isolates for the MS-2; 12 of 9 isolates for the Lumac) gram-positive cocci. The Lumac system was the most costly, being 3.6 times as expensive as the standard plate method. Although both systems greatly reduce the time required to process urine specimens, the large number of false-positive results, false-negative results at greater than 10(4) to 10(5) CFU/mL, as well as cost suggest that a careful evaluation of a laboratory's specific needs for urine cultures be made to determine whether or not such rapid urine screening systems are appropriate.